SEI Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.9M Buy
25,826
+1,628
+7% +$834K 0.01% 971
2026
Q1
$12.7M Buy
24,198
+1,122
+5% +$536K 0.01% 1007
2025
Q4
$13.4M Buy
23,076
+3,961
+21% +$2.02M 0.01% 916
2025
Q3
$8.77M Buy
19,115
+1,573
+9% +$587K 0.01% 1071
2025
Q2
$5.31M Buy
17,542
+1,547
+10% +$461K 0.01% 1248
2025
Q1
$5.3M Buy
15,995
+7,766
+94% +$2.55M 0.01% 1243
2024
Q4
$2.54M Sell
8,229
-1,023
-11% -$288K ﹤0.01% 1589
2024
Q3
$1.96M Sell
9,252
-547
-6% -$140K ﹤0.01% 1695
2024
Q2
$2.75M Sell
9,799
-656
-6% -$156K ﹤0.01% 1508
2024
Q1
$2.79M Sell
10,455
-463
-4% -$109K ﹤0.01% 1473
2023
Q4
$2.53M Buy
10,918
+830
+8% +$145K ﹤0.01% 1498
2023
Q3
$1.47M Sell
10,088
-3,176
-24% -$598K ﹤0.01% 1734
2023
Q2
$3.06M Buy
13,264
+5,221
+65% +$1.41M 0.01% 1443
2023
Q1
$1.95M Buy
8,043
+2,779
+53% +$757K ﹤0.01% 1638
2022
Q4
$1.53M Buy
+5,264
New +$515K ﹤0.01% 1606
2022
Q2
Sell
-2,823
Closed -$277K 2690
2022
Q1
$277K Buy
2,823
+80
+3% +$6.75K ﹤0.01% 2334
2021
Q4
$232K Sell
2,743
-234
-8% -$19.2K ﹤0.01% 2425
2021
Q3
$238K Hold
2,977
﹤0.01% 2394
2021
Q2
$290K Buy
+2,977
New +$352K ﹤0.01% 2325
2019
Q1
Sell
-465
Closed -$100K 2948
2018
Q4
$100K Hold
465
﹤0.01% 2200
2018
Q3
$100K Sell
465
-5,291
-92% -$1.33M ﹤0.01% 2081
2018
Q2
$1.61M Buy
+5,756
New +$1.01M 0.01% 1410

Other funds holding MDGL

SEI Investments's MDGL Position: Q2 2026 in Review

SEI Investments increased its Madrigal Pharmaceuticals (MDGL) stake by 6.7% in Q2 2026, buying an estimated $834K and bringing the position to 25,826 shares worth $13.9M. The position accounts for 0.01% of the portfolio, ranked #971.

SEI Investments first reported a position in MDGL in Q2 2018 and has held it in 22 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • SEI Investments held 25,826 shares of Madrigal Pharmaceuticals worth $13.9M as of Q2 2026.
  • SEI Investments bought 1,628 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $834K.
  • Madrigal Pharmaceuticals made up 0.01% of SEI Investments's portfolio in Q2 2026, its #971 holding.
  • SEI Investments first reported a position in Madrigal Pharmaceuticals in Q2 2018 and has held it in 22 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.